By Meghan McCarthy, CQ Staff
More competition among manufacturers of brand name and generic will create better and cheaper biotech drugs, according to a study released Wednesday by the generic pharmaceutical company Teva Pharmaceuticals USA.
Conducted by Boston University Economics Professor Larry Kotlikoff, the study invokes traditional economic theory as it argues that monopolies discourage innovation, which flourishes in a competitive environment.
Continue reading Report: Increased Competition Will Produce Better, Cheaper Medicines .
![[RSS]](http://67.192.49.194/templates/images/rss_icon.gif){kind=icon}
